Accreditation Statement:

Creative Educational Concepts, Inc. (CEC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CEC designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Each activity within this 4 part series is accredited for a maximum of 1.0 AMA PRA Category 1 Credits™. You must complete all four (4) activities in order to receive 4.0 AMA PRA Category 1 Credits™.

To receive a statement of credit, you must:

• Review the full content of the activity and reflect upon its teachings
• Complete the questions and evaluation at the end of the activity

Your statement of credit will be issued immediately upon successful completion of the evaluation form.

Activity 1: Presentation and Diagnosis of OSA in Primary Care (Phyllis Zee, MD)

Activity 2: OSA and the Principles of Therapy (B. Tucker Woodson, MD)

Activity 3: Management of OSA from a Primary Care Perspective (Amit Khanna, MD)
Release Date: January 31, 2011
Expiration Date: January 31, 2013

Activity 4: What's New in Obstructive Sleep Apnea: 2011 and Beyond (Amit Khanna, MD)
Release Date: April 4, 2011
Expiration Date: April 4, 2013

Disclosure Policy:

It is the policy of CEC to ensure independence, balance, objectivity, scientific rigor, and integrity in their continuing education activities.

Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all presentation materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by CEC for any product or manufacturer identified.

Unlabeled Use Disclosure

This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.

Faculty Disclosure Declaration:

Kingman P. Strohl, MD (program chair)
Disclosures:
Grant/Research Support: National Institute of Health; VA Medical Center; Inspire Medical.
Medical Advisory Board: Novosom Inc. (formally known as Sleep Solutions, Inc); SleepMed, Inc.
Stockholder: IonSleep LLC; Nanotechnology, LLC.
Other: Medical Director, SleepMed, Inc.

Amit Khanna, MD, D.ABSM, D.ABFM
Disclosures:
Consultant: NovaSom Inc.

B. Tucker Woodson, MD, FACS, D.ABSM
Disclosures:
Grant/Research Support: Aspire Medical.
Stock options: Aspire Medical; Royalty Patent.

Phyllis Zee, MD, PhD
Disclosures:
Grant/Research Support: Takeda.
Consultant: Takeda; Sanofi-Aventis; GlaxoSmithKline
Speakers' Bureau: Takeda.